Daiwa Securities Group Inc. - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 87 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$1,0000.0%1420.0%0.00%
Q2 2019$1,0000.0%1420.0%0.00%
Q1 2019$1,0000.0%1420.0%0.00%
Q4 2018$1,000
-66.7%
1420.0%0.00%
Q3 2018$3,000
-25.0%
1420.0%0.00%
Q2 2018$4,000
+33.3%
1420.0%0.00%
Q1 2018$3,0001420.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,423,578$8,826,0006.08%
Healthcare Value Capital, LLC 200,000$1,240,0002.33%
ARMISTICE CAPITAL, LLC 2,700,000$16,740,0001.06%
DELTEC ASSET MANAGEMENT LLC 550,836$3,415,0000.75%
Broadfin Capital, LLC 441,088$2,735,0000.60%
Kerrisdale Advisers, LLC 229,347$1,422,0000.51%
Worth Venture Partners, LLC 87,908$545,0000.30%
Mosaic Family Wealth, LLC 91,314$566,0000.24%
EMERALD ADVISERS, LLC 700,176$4,341,0000.17%
EMERALD MUTUAL FUND ADVISERS TRUST 616,664$3,823,0000.15%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders